Heron says drug for post-surgery pain succeeds in midstage trial

(Reuters) - Heron Therapeutics Inc on Wednesday said its experimental combination drug for post-operative pain led to significant reductions in pain intensity and need for opioids, according to initial data from a midstage trial.